Conversely, semaglutide, with strong cardiovascular outcomes and weight-loss efficacy, may be better suited for individuals with obesity, T2DM, or high cardiometabolic risk, where it can improve histology and provide extra-hepatic benefits through calorie reduction and glycemic control
Instead, it is FDA approved for managing Type 2 diabetes
Incorporating nutrient- and herb- based interventions offer patients a safer, more integrated path towards improved metabolic health and weight management
Mounjaro is prescribed for adults who have obesity or a weight-related health condition
The inhibition of cancer cell growth by GLP-1RAs through regulating cAMP-dependent signaling GLP-1 receptor (GLP-1R) activation leads to adenylyl cyclase activation, subsequently inducing a substantial increase in intracellular cyclic adenosine monophosphate (cAMP) levels
True Value Score: A- Pricing *Requires in-network insurance coverage